Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram Positive Bacteria”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT00035269
What this trial is testing

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Who this might be right for
Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
Pfizer 230
Not applicableStudy completedNCT01631461
What this trial is testing

Painful Breastfeeding and Bacterial or Yeast Infection

Who this might be right for
Breast Infection
Göteborg University 136
Not applicableNot Yet RecruitingNCT07013552
What this trial is testing

Oritavancin for CIED Infections With MDR Gram-positive Cocci

Who this might be right for
Cardiac Implantable Electronic Device InfectionsInfective EndocarditisMultidrug-resistant Bacteria Screening+4 more
Medical University of Silesia 100
Not applicableNot Yet RecruitingNCT06370299
What this trial is testing

Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient

Who this might be right for
Multi-antibiotic Resistance
Region Skane 10,000
Not applicableEnded earlyNCT03869593
What this trial is testing

Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria

Who this might be right for
Escherichia Coli InfectionsStaphylococcus Aureus
Centre Hospitalier Universitaire de Nice 60
Not applicableStudy completedNCT02180906
What this trial is testing

Biomarkers in Patients With Flesh-eating Bacterial Infections

Who this might be right for
Necrotizing Soft Tissue InfectionNecrotizing FasciitisGas Gangrene+1 more
Ole Hyldegaard 169
Not applicableStudy completedNCT03250104
What this trial is testing

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives

Who this might be right for
Clostridium Difficile InfectionVRE InfectionNosocomial Infection+1 more
University Hospital of Cologne 80,000
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Not applicableStudy completedNCT02838407
What this trial is testing

Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 197
Post-approval studies (Phase 4)Study completedNCT01193582
What this trial is testing

Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Who this might be right for
Pneumococcal Infections
Pfizer 505
Not applicableEnded earlyNCT04200508
What this trial is testing

Targeted Gown and Glove Intervention in Nursing Homes

Who this might be right for
Staphylococcus AureusCarbapenem Resistant Gram Negative Bacteria
University of Maryland, Baltimore 4
Not applicableStudy completedNCT01204385
What this trial is testing

Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 66
Not applicableStudy completedNCT05605275
What this trial is testing

CRP and PCT as Predictors of Sepsis Cause

Who this might be right for
SepsisGram-Positive BacteremiaGram-negative Bacteremia
Osijek University Hospital 81
Not applicableStudy completedNCT01861457
What this trial is testing

Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic

Who this might be right for
Infectious Disease
Medical University of South Carolina 39
Not applicableStudy completedNCT04959799
What this trial is testing

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Who this might be right for
DiabetesInfection
Aziende Chimiche Riunite Angelini Francesco S.p.A 98
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Not applicableWithdrawnNCT01160055
What this trial is testing

Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00071214
What this trial is testing

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

Who this might be right for
Staphylococcal InfectionsKidney Failure, Chronic
Nabi Biopharmaceuticals 3,600
Not applicableStudy completedNCT00000933
What this trial is testing

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV InfectionsPneumococcal Infections
National Institute of Allergy and Infectious Diseases (NIAID) 326
Not applicableStudy completedNCT03159403
What this trial is testing

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

Who this might be right for
Gram-Positive Bacterial Infections
Melinta Therapeutics, Inc. 325
Load More Results